Navigation Links
Arthritis Trial Leads to Potential Cure for High Blood Pressure

An Australian company may have stumbled across a cure for high blood pressure and heart disease during a clinical trial for osteoarthritis.

Bendigo, Victoria (PRWEB) April 6, 2009 -- The Elmore Oil Company, a Bendigo based company who manufactures a topical pain relief lotion for arthritis and muscular pain, recently undertook a double blind placebo controlled trial for their flagship product, Elmore Oil.

The trial was headed by Dr. Ruth S. Sy, head Rheumatologist at the Veterans Memorial Hospital in Quezon City and co-ordinated by respected researcher, Dr. Leticia Lucero-Palma. In what could be a major breakthrough in medical science, all the patients in the trial have recorded reduced uric acid levels after being in the program for as little as 4 weeks.

The trial was set up to study the effects of Elmore Oil against a placebo, on patients aged between 45 and 90 years of age, who have been clinically diagnosed with osteoarthritis. The patients all recorded their pain levels in a detailed diary but they have also been blood tested prior to the trial and weekly thereafter.

Dr. Palma noticed a marked drop in uric acids levels in all patients, up to 50% in some cases, which has led to an excited optimism that the company may have stumbled on a potential cure for high blood pressure and heart disease, as well as debilitating diseases like gout. While it is too early to make assumptions the company is prepared to fund more research into the potential cure.

A story on the effects of the product for arthritis, as well as the uric acid discovery, was recently aired on Australias leading news program, A Current Affair, in the first week of April.

According to an article published in the Journal of the American Medical Association, high uric acid levels can definitely lead to heart disease. Doctors studied nearly 6,000 people over a 20 year period. Approximately 1,500 of the people died, mostly from heart trouble. Researchers studied the patients' uric acid levels and found that an elevated uric acid level, not quite high enough to cause gout, could lead to heart disease and even death -- and the higher the uric acid level, the greater the risk.

Elmore Oil is a simple blend of Olive Oil, Eucalyptus Oil, Tea Tree Oil and specially prepared extracts of Vanilla. The companies Managing Director, Mark Linford, says the secret behind Elmore Oil is its unique blending process.

"Elmore Oil is manufactured using a process known as Triple Maturation. It's unique to Elmore Oil and it bonds the actives in the essentials oils to the circulatory components found in Vanilla so we have a product which enters the body quickly and gets to the source of the pain and inflammation quickly."

This advantage has been the driving factor behind the products spiralling popularity with the elderly generation for arthritis pain relief, but it has also struck favour with the younger and mid age groups as a recovery product for exercise and sport. Now with the potential to be used as a preventative for conditions like high blood pressure, kidney disease, heart disease and gout, the product could be set for multi national fame.

"We are hopeful that the next phase of the trial can isolate the components that are lowering the uric acid levels and allow us to pin point the science behind this amazing revelation."


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Living Near Major Road May Boost Rheumatoid Arthritis Risk
2. Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia
3. Arthritis Treatments and Joint Pain Relief Ideas Featured on Newly Launched Arthritis Today Web Site
4. As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis
5. Exercise Physiologist and Celebrity Trainer Bob Greene Leads National Campaign to Showcase Osteoarthritis Pain Management Techniques and New Treatment Approaches
6. CMEFirst Presents State-of-the-Art Arthritis CME Symposium
7. BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis
8. PetCareRx Reinforces its Range of Arthritis and Joint Care Products for Winter
9. Hip Osteoarthritis Therapy No Better Than Placebo
10. Immune cells from patients with rheumatoid arthritis have prematurely aged chromosomes
11. Arthritis hinders physical activity for adults with heart disease
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... Association meeting in Washington D.C. revolved around the fact that proper dental care, both ... talk stressed the link between periodontal disease (more commonly referred to as gum disease) ...
(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 27, 2015 ... --> --> ... emergency response system (PERS) market ... for 5 years with APAC ... expected to see a high ...
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
Breaking Medicine Technology: